About Cureos
Cureos is a company based in Delhi (India) founded in 2020 by Siddhartha Nautiyal. Cureos has raised $280.34 thousand across 1 funding round from investors including Amit Ahuja, Dharmendra Kumar Rao and Amit Ahuja. Cureos operates in a competitive market with competitors including Dr. Mohan’s Diabetes Specialities Centre, Apollo Sugar, Lifespan, DiabManage and Samatvam, among others.
- Headquarter Delhi, India
- Founders Siddhartha Nautiyal
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Rxos Healthcare Private Limited
- Date of Incorporation 08 Jan, 2020
- Jurisdiction New Delhi, Delhi, India
-
Annual Revenue
$4.41 K (USD)-95.5as on Mar 31, 2022
-
Net Profit
-$23.56 K (USD)87.5as on Mar 31, 2022
-
EBITDA
-$22.84 K (USD)86.86as on Mar 31, 2022
-
Total Equity Funding
$280.34 K (USD)
in 1 rounds
-
Latest Funding Round
$280.34 K (USD), Angel Round
Feb 14, 2020
-
Investors
& 3 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Cureos
Cureos has successfully raised a total of $280.34K through 1 strategic funding round. The most recent funding activity was a Angel Round of $280.34 thousand completed in February 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Cureos
Cureos has secured backing from 4 investors, including angel investors. Prominent investors backing the company include Amit Ahuja, Dharmendra Kumar Rao and Amit Ahuja.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
AA
Amit Ahuja |
Angel investor and entrepreneur, focused on tech startups, ex-Cisco executive
|
Locked | Locked | Locked |
|
DK
Dharmendra Kumar Rao |
-
|
Locked | Locked | Locked |
|
AA
Amit Ahuja |
-
|
Locked | Locked | Locked |
Investor details for Cureos
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cureos
Investment portfolio details for Cureos
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Cureos
Detailed financials for Cureos
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cureos Comparisons
Peer comparison for Cureos
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cureos
Cureos operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Dr. Mohan’s Diabetes Specialities Centre, Apollo Sugar, Lifespan, DiabManage and Samatvam, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Chain of diabetes speciality centre
|
|
| Locked | Locked | Locked |
Apollo Sugar runs a chain of clinics focused on diabetes management and treatment.
|
|
| Locked | Locked | Locked |
Chain of diabetes & cardio metabolism clinics
|
|
| Locked | Locked | Locked |
Diabetes care is delivered via a chain of specialized clinics.
|
|
| Locked | Locked | Locked |
Online retailer specializing in Indian festive and Western fashion apparel.
|
Detailed competitors of Cureos
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cureos
Complete news archive for Cureos
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cureos
Cureos was founded in 2020.
Cureos is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
Cureos is a funded company, having raised a total of $280.34K across 1 funding round to date.
Annual revenue of Cureos is $4.41K as on Mar 31, 2022.
Cureos was founded in 2020 and is based in Delhi, India. Operations are centered on a network of clinics dedicated to diabetes management and care. Services encompass routine check-ups, treatment plans, and patient education in the healthcare sector. The company is led by co-founder and COO Siddhartha Nautiyal, with activities primarily serving the Indian market through its domain cureos.in.
Cureos's top competitors include Dr. Mohan’s Diabetes Specialities Centre, Apollo Sugar and Lifespan.
Cureos has 4 investors. Key investors include Amit Ahuja, Dharmendra Kumar Rao, Amit Ahuja, and Dharmendra Rao.
The valuation of Cureos is $1.4M as of Feb 2020.